SRPT SRPT

Sarepta Therapeutics Stock Price

122.81
0.00 (0.0%)
122.81
Volume 4
Bid Price 117.50
Ask Price 124.87
News -
Day High

Low
61.28

52 Week Range

High
123.66

Day Low
Company Name Stock Ticker Symbol Market Type
Sarepta Therapeutics Inc New SRPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 122.81 07:00:23
Open Price Low Price High Price Close Price Prev Close
122.81
Trades Volume Avg Volume 52 Week Range
2 4 - 61.28 - 123.66
Last Trade Time Type Quantity Stock Price Currency
07:00:31 1 $ 123.00 USD

Period:

Draw Mode:

Sarepta Therapeutics Inc New Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 10.78B 87.78M 83.91M $ 701.89M $ -581.86M -5.15 -14.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 103.27k 17.60%

more financials information »

Sarepta Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SRPT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week114.57123.66113.7901119.221,213,0008.247.19%
1 Month106.89123.66100.15110.131,027,14615.9214.89%
3 Months113.63123.66100.15111.101,103,9519.188.08%
6 Months72.67123.6661.28101.171,016,56550.1469.0%
1 Year80.66123.6661.2889.96950,32842.1552.26%
3 Years112.60181.8361.28101.601,025,98610.219.07%
5 Years56.29181.8350.68104.401,147,97266.52118.17%

Sarepta Therapeutics Description

Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.